Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 LY121019 inhibits Neurospora crassa growth and (1-3)-beta-D-glucan synthase.

× No keyword cloud information.

9 in total

1. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase.

Authors: J Tang; T R Parr
Journal: Antimicrob Agents Chemother Date: 1991-01 Impact factor: 5.191

Review 2. Compounds active against cell walls of medically important fungi.

Authors: R F Hector
Journal: Clin Microbiol Rev Date: 1993-01 Impact factor: 26.132

3. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.

Authors: D W Denning; D A Stevens
Journal: Antimicrob Agents Chemother Date: 1991-07 Impact factor: 5.191

4. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.

Authors: T J Walsh; J W Lee; P Kelly; J Bacher; J Lecciones; V Thomas; C Lyman; D Coleman; R Gordee; P A Pizzo
Journal: Antimicrob Agents Chemother Date: 1991-07 Impact factor: 5.191

5. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.

Authors: M B Kurtz; C Douglas; J Marrinan; K Nollstadt; J Onishi; S Dreikorn; J Milligan; S Mandala; J Thompson; J M Balkovec
Journal: Antimicrob Agents Chemother Date: 1994-12 Impact factor: 5.191

6. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Authors: M B Kurtz; I B Heath; J Marrinan; S Dreikorn; J Onishi; C Douglas
Journal: Antimicrob Agents Chemother Date: 1994-07 Impact factor: 5.191

LY121019 inhibits Neurospora crassa growth and (1-3)-beta-D-glucan synthase.

1. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase.

Review 2. Compounds active against cell walls of medically important fungi.

3. Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis.

4. Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.

5. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.

6. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

7. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-beta-D-glucan synthase.

8. Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.

9. Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.